These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 35902905)

  • 1. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
    Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
    BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
    Fu XW; Song CQ
    Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
    Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
    PeerJ; 2023; 11():e14691. PubMed ID: 36650832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs.
    Wu T; Li N; Luo F; Chen Z; Ma L; Hu T; Hong G; Li H
    BMC Bioinformatics; 2023 Apr; 24(1):176. PubMed ID: 37120506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pyroptosis-Based Prognostic Model for Immune Microenvironment Estimation of Hepatocellular Carcinoma.
    Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Jin H; Shi N
    Dis Markers; 2022; 2022():8109771. PubMed ID: 35047095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
    Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
    [No Abstract]   [Full Text] [Related]  

  • 9. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.
    Chen X; Yang M; Wang L; Wang Y; Tu J; Zhou X; Yuan X
    BMC Cancer; 2023 May; 23(1):411. PubMed ID: 37149620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma.
    Li Y; Li Y; Zhang X; Duan X; Feng H; Yu Z; Gao Y
    Front Oncol; 2022; 12():986827. PubMed ID: 36267972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma.
    Wang H; Zhang B; Shang Y; Chen F; Fan Y; Tan K
    Aging (Albany NY); 2023 Feb; 15(5):1412-1444. PubMed ID: 36920176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pyroptosis-Related Signature Composed of GSDMC Predicts Prognosis and Contributes to Growth and Metastasis of Hepatocellular Carcinoma.
    Li M; Jiang Q; Liu X; Han L; Chen S; Xue R
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):235. PubMed ID: 37919059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of a pyroptosis-related gene signature in hepatocellular carcinoma based on RNA sequencing.
    He J; Ran J; Li J; Chen D
    Transl Cancer Res; 2022 Jun; 11(6):1510-1522. PubMed ID: 35836524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
    Li H; Li T; Zhang X
    Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Pyroptosis Gene Signature Related Molecular Pattern, Clinical Implication, and Tumor Immunity in Hepatocellular Carcinoma`.
    Li YT; Zeng XZ
    Comb Chem High Throughput Screen; 2023; 26(7):1324-1336. PubMed ID: 36017840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma.
    Xing M; Li J
    BMC Bioinformatics; 2022 May; 23(1):177. PubMed ID: 35562678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.